Abstract
Deterioration of pulmonary function can be the sole symptom of early stages of pulmonary complications following allogeneic hematopoietic cells transplantation (alloHCT). The aim of the study was to evaluate the prevalence and types of pulmonary function abnormalities in allogenic cells recipients. Twenty three (5 children and 18 adults) allogeneic hematopoietic cells recipients who underwent pulmonary function assessment before and 6–12 months after alloHCT were included in the study. Forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), total lung capacity (TLC), and lung diffusion capacity for carbon dioxide (DLCO) were determined. Values <80% of predicted were considered abnormal. We found significant reductions of FVC, DLCO, and TLC after alloHCT. The most important reduction was noted in DLCO (pre-alloHCT of 85%±15% vs. post- alloHCT of 60% ± 21%, p< 0.05). Six patients (26%) presented with lung function impairment before alloHCT: obstructive lung disease (4%), restrictive lung disease (13%), and decreased DLCO (17%). In 19 patients (83%) pulmonary function abnormalities were demonstrated after alloHCT. The most common disturbance was a DLCO decrease that occurred in 16 patients (70%). In conclusion, frequency of pulmonary function abnormalities in patients after alloHCT is high. A diffusion capacity decrease and restrictive pattern of ventilation insufficiency develop in the majority of patients after alloHCT. It would be reasonable to include pulmonary function testing to standard periodic examination in patients qualified for, and after, alloHCT procedure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Thoracic Society. (1987). Standardization of spirometry – 1987 update. American Review of Respiratory Disease, 136, 1285–1298.
Cerveri, I., Zoia, M. C., Fulgoni, P., Corsico, A., Casali, L., Tinelli, C., Zecca, M., Giorgiani, G., & Locatelli, F. (1999). Late pulmonary sequelae after childhood bone marrow transplantation. Thorax, 54, 131–135.
Chien, J. W., Martin, P. J., Gooley, T. A., Flowers, M. E., Heckbert, S. R., Nichols, W. G., & Clark, J. G. (2003). Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. American Journal of Respiratory and Critical Care Medicine, 168, 208–214.
Chien, J. W., Martin, P. J., Flowers, M. E., Nichols, W. G., & Clark, J. G. (2004). Implications of early airflow decline after myeloablative allogeneic stem cell transplantation. Bone Marrow Transplantation, 33, 759–764.
Clark, J. G., Schwartz, D. A., Flournoy, N., Sullivan, K. M., Crawford, S. W., & Thomas, E. D. (1987). Risk factors for airflow obstruction in recipients of bone marrow transplants. Annals of Internal Medicine, 107, 648–656.
Depledge, M., Barrett, A., & Powles, R. (1983). Lung function after bone marrow grafting. International Journal of Radiation Oncology, Biology, and Physics, 9, 141–151.
Eikenberry, M., Bartakova, H., Defor, T., Haddad, I. Y., Ramsay, N. K., Blazar, B. R., Milla, C. E., & Cornfield, D. N. (2005). Natural history of pulmonary complications in children after bone marrow transplantation. Biology of Blood and Marrow Transplantation, 11, 56–64.
Fanfulla, F., Locatelli, F., Zoia, M. C., Giorgian, G., Bonetti, F., Spagnolatti, L., & Cerveri, I. (1997). Pulmonary complications and respiratory function changes after bone marrow transplantation in children. European Respiratory Journal, 10, 2301–2306.
Frisk, P., Arvidson, J., Bratteby, L.-E., Hedenström, H., & Lönnerholm, G. (2004). Pulmonary function after autologous bone marrow transplantation in children: A long-term prospective study. Bone Marrow Transplantation, 33, 645–650.
Ghalie, R., Szidon, J. P., Thompson, L., Nawas, Y. N., Dolce, A., & Kaizer, H. (1992). Evaluation of pulmonary complications after bone marrow transplantation: The role of pretransplant pulmonary function tests. Bone Marrow Transplantation, 10, 359–365.
Griese, M., Rampf, U., Hofmann, D., Fuhrer, M., Reinhardt, D., & Bender-Gotze, C. (2000). Pulmonary complications after bone marrow transplantation in children: Twenty-four years of experience in a single pediatric center. Pediatric Pulmonology, 30, 393–401.
Kaplan, E. B., Wodell, R. A., Wilmott, R. W., Leifer, B., Lesser, M. L., & August, C. S. (1994). Late effects of bone marrow transplantation on pulmonary function in children. Bone Marrow Transplantation, 14, 613–621.
Kaya, Z., Weiner, D., Yilmaz, D., Rowan, J., & Goyal, R. K. (2009). Lung function, pulmonary complications, and mortality after allogeneic blood and marrow transplantation in children. Biology of Blood and Marrow Transplantation, 15, 817–826.
Kotloff, R. M., Ahya, V. N., & Crawford, S. W. (2004). Pulmonary complications of solid organ and hematopoietic stem cell transplantation. American Journal of Respiratory and Critical Care Medicine, 170, 22–48.
Michelson, P. H., Goyal, R., & Kurland, G. (2007). Pulmonary complications of haematopoietic cell transplantation in children. Paediatric Respiratory Reviews, 8, 46–61.
Nysom, K., Holm, K., Hesse, B., Ulrik, C. S., Jacobsen, N., Bisgaard, H., & Hertz, H. (1996). Lung function after allogeneic bone marrow transplantation for leukaemia or lymphoma. Archives of Disease in Childhood, 74, 432–436.
Quabeck, K. (1994). The lung as a critical organ in marrow transplantation. Bone Marrow Transplantation, 14(Suppl 4), 19–28.
Quanjer, P. H., Dalhuijsen, A., & van Zomren, B. C. (1983). Summary equations of reference values. Clinical Respiratory Physiology, 19, 45–51.
Quigly, P. M., Yeager, A. M., & Loughlin, G. M. (1994). The effects of bone marrow transplantation on pulmonary function in children. Pediatric Pulmonology, 18, 361–367.
Rodriguez-Roisin, R., Granena, A., Agusti, A. G. N., Marín, P., & Rozman, C. (1989). Lung function in allogeneic bone marrow transplantation recipients. European Respiratory Journal, 2, 359–365.
Roychowdhury, M., Pambuccian, S. E., Aslan, D. L., Jessurun, J., Rose, A. G., Manivel, J. C., & Gulbahce, H. E. (2005). Pulmonary complications after bone marrow transplantation: An autopsy study from a large transplantation center. Archives of Pathology & Laboratory Medicine, 129, 366–371.
Soubani, A. O., Miller, K. B., & Hassoun, P. M. (1996). Pulmonary complications of bone marrow transplantation. Chest, 109, 1066–1077.
Sutedja, T., Apperley, J. F., Hughes, J. M. B., Aber, V. R., Kennedy, H. G., Nunn, P., Jones, L., Hopper, L., & Goldman, J. M. (1988). Pulmonary function bone marrow transplantation for chronic myeloid leukaemia. Thorax, 43, 163–169.
Conflicts of Interest: The authors declare no conflicts of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this paper
Cite this paper
Piesiak, P., Gorczynska, E., Brzecka, A., Kosacka, M., Jankowska, R. (2013). Pulmonary Function Impairment in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation. In: Pokorski, M. (eds) Respiratory Regulation - Clinical Advances. Advances in Experimental Medicine and Biology, vol 755. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4546-9_19
Download citation
DOI: https://doi.org/10.1007/978-94-007-4546-9_19
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-4545-2
Online ISBN: 978-94-007-4546-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)